In view of this role, we examined the Rac1 GTP binding activity in splenic T-cells from normal chow diet and MK0431-treated NOD mice. whereas treatment after transplantation alone resulted in small beneficial effects compared with nontreated controls. Subsequent studies shown that MK0431 pretreatment resulted in decreased insulitis in diabetic NOD mice and Capreomycin Sulfate reduced in vitro migration of isolated splenic CD4+T-cells. Furthermore, in vitro treatment of splenic CD4+T-cells with DPP-IV resulted in improved migration and activation of protein kinase A (PKA) and Rac1. CONCLUSIONSTreatment with MK0431 consequently reduced the effect of autoimmunity on graft survival partially by reducing the homing of CD4+T-cells into pancreatic -cells through a pathway including cAMP/PKA/Rac1 activation. The incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), exert a number of actions that improve glucose homeostasis, including potentiation of glucose-stimulated insulin secretion (GSIS), promotion of -cell proliferation and survival, and inhibition of glucagon secretion (17). Because GIP and GLP-1 are rapidly degraded from the endopeptidase dipeptidyl peptidase IV (DPP-IV; CD26), it has not Capreomycin Sulfate been possible to directly take advantage of their beneficial actions for the treatment of type 2 diabetes (8,9). Consequently, a number of strategies have been explored to circumvent this problem, including the development of small molecule (10,11) and DPP-IVresistant peptide (12,13) incretin receptor agonists, and DPP-IV inhibitors (14,15). Users of two classes of compounds have recently been approved by the Food and Drug Administration as type 2 diabetes therapeutics: the DPP-IVresistant GLP-1 receptor agonist (incretin mimetic) exenatide (Byetta) and the DPP-IV inhibitor sitagliptin (Januvia). Although DPP-IV inhibitors have been extensively analyzed in treatment of type 2 diabetes, little is known about their potential for treatment of type 1 diabetes. Infusion of GLP-1 was shown to reduce glycemic excursions in type 1 diabetic patients, and this result was attributed to reduced glucagon levels and delayed gastric emptying (16,17). In preclinical studies, the DPP-IV inhibitor isoleucine thiazolidide was shown to improve glucose tolerance in both streptozotocin (STZ)-induced (18,19) and BioBreeding (BB) Capreomycin Sulfate (19) diabetic rats, associated with improved -cell survival and possibly islet neogenesis (18). Additionally, we recently showed the DPP-IV inhibitor MK0431 long term islet graft survival in STZ-induced diabetic mice (20). In the current study, we display that MK0431 pretreatment resulted in the prolongation of islet graft survival in an autoimmune type 1 diabetes model, the nonobese diabetic (NOD) mouse, through a mechanism that includes modulation of CD4+T-cell migration. == Study DESIGN AND METHODS == NOD/LtJ mice (NOD, H2g7) were purchased from your Jackson Laboratories (Pub Harbor, ME). Mice (810 weeks aged) were placed on either a normal chow diet (Purina Rodent Chow 5015) or diet comprising Sitagliptin (MK0431) (21) (Purina Rodent Chow 5015 plus 4 g MK0431/kg; Study Diet programs, New Brunswick, NJ) ad libitum. From your mice that had been Rabbit Polyclonal to TBX3 fed a normal chow diet, two groups of diabetic mice were studied. Immediately after the islet transplantation, group 1 mice received the normal chow diet for the remainder of the study (NCD Tx), whereas group 2 mice were fed the MK0431-comprising diet (Post MK0431 Tx). Group 3 mice were animals that experienced received the MK0431 diet for one month before surgery and for the remainder of the study (Pre MK0431 Tx). In a second study, mice were fed either normal chow diet or MK0431 for a period of 4 weeks. All animal experiments were conducted in accordance with the guidelines put forth by the University or college of English Columbia Committee on Animal Care and the Canadian Council on Animal Care. == DPP-IV activity assays. == To measure the plasma DPP-IV activity, a fluorometric assay was used as previously explained (20). == Islet isolation and islet gene transfer. == Islets were isolated from nondiabetic male NOD/LtJ mice (812 weeks aged) by collagenase digestion (22). Recombinant adenovirus-expressing HSV1-Sr39TK was produced and expanded by illness of human being embryonic kidney-293 cells (23). Islets were exposed to rAD-TK as previously explained (20,24,25). == Islet transplantation. == A cohort of 70 female NOD/LtJ mice was divided into two randomly selected groups of 35, and from the age of 810 weeks, one group of mice received a normal chow diet while the second received Capreomycin Sulfate a diet comprising MK0431 (4 g/kg). When mice developed diabetes, defined as a blood glucose level of 15 mmol/l for 3 consecutive days, they received an islet transplant. Islets (200 from nondiabetic male NOD/LtJ mice and.